The bradykinin B2-receptor in human decidua

Area of Science:

• Reproductive biology
• Molecular endocrinology
• Immunology

Background:

• Bacterial infections causing preterm delivery activate mediators in fetal membranes.
• Bradykinin and its B2-receptor (B2R) are implicated in this inflammatory pathway.
• Decidual cells are key in mediating uterine contractions during pregnancy.

Purpose of the Study:

• To investigate the role of bradykinin and B2R in human decidua-derived cells.
• To determine if B2R signaling contributes to decidual activation and preterm labor.
• To explore potential therapeutic targets for chorioamnionitis.

Main Methods:

• Culture of human decidua-derived cells.
• Stimulation with bradykinin and interleukin-1beta.
• Measurement of mediator release (arachidonic acid, IL-6, IL-8).
• B2R antagonist (Hoe 140) treatment.
• Immunocytochemistry and RT-PCR for B2R expression.
• Bradykinin binding studies.

Main Results:

• Bradykinin stimulates arachidonic acid, IL-6, and IL-8 release from decidua cells.
• These effects are blocked by the B2R antagonist Hoe 140.
• Decidua cells express B2R mRNA and protein, with specific binding sites for bradykinin.
• Interleukin-1beta upregulates B2R expression and bradykinin binding.

Conclusions:

• Human decidua-derived cells express functional B2R, which is upregulated by inflammation.
• Bradykinin signaling through B2R promotes mediator release, suggesting a role in decidual activation.
• B2R antagonists represent a potential adjunct therapy for chorioamnionitis-induced preterm labor.